Concepedia

Alicia Roig‐Merino

AR

5

Publications

112

Citations

5

H-Index

2021

Active since

Affiliations

MaxCyte (United States)(Current)

Heidelberg University

Manchester Metropolitan University

University Children's Hospital Tübingen

DKFZ-ZMBH Alliance

Alicia Roig‐Merino is an author at MaxCyte (United States) specializing in crispr, cellular therapies, and gene editing.

ORCID

Top concepts

Publications per year

2021–2023

5

Publications

5

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL

Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou et al. · International Journal of Molecular Sciences · 2022 · 47 citations · Full text

, , +18

An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny

Alicia Roig‐Merino, Manuela Urban, Matthias Bozza et al. · Stem Cell Reports · 2021 · 23 citations · Full text

Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency

Tobias Braun, Alina Pruene, Milita Darguzyte et al. · Frontiers in Immunology · 2023 · 17 citations · Full text

CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells

Tahereh Mohammadian Gol, Miso Kim, Ralph Sinn et al. · International Journal of Molecular Sciences · 2023 · 15 citations · Full text

Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors

Christopher D. Thornton, Stuart Fielding, Kinga Karbowniczek et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 10 citations · Full text

Rows per page

1–5 of 5